Task: Answer Verification
Input (English): Question: Does food influence the pharmacokinetics of a new extended release formulation of tolterodine for once daily treatment of patients with overactive bladder?
Answer: The new ER formulation of tolterodine shows no pharmacokinetic interaction with food. On the basis of these results, patients with overactive bladder may, therefore, be advised to take the drug without regard to the timing of meals, maximising convenience during therapy.
Output (English): no